EndoGastric Solutions has started TIF versus Medical Proton Pump Inhibitor (PPI) Management of Refractory GERD Symptoms (TEMPO) trial. The controlled, multi-center, open-label, prospective, randomized study, which will enroll 51 patients, ...
Tags: EndoGastric Solutions, TEMPO trial, study, TIF
Eisai's Aciphex (rabreprazole sodium) has met the FDA's Written Request requirements for pediatric exclusivity in US. Having met FDA's requirement, the company has now gained an additional 6 months US market exclusivity for Aciphex, which ...
Tags: rabreprazole sodium, FDA, Aciphex, pediatric drug, GERD Drug
EndoStim has received CE mark approval for its LES Stimulation system, designed to treat gastro-esophageal reflux disease (GERD) and eliminate the need for daily proton pump inhibitor (PPI) medication. By using low energy electrical ...
Outokumpu delivered duplex stainless steel for biogas tanks built by German biogas tank manufacturer Börger GmbH. Tanks built in LDX 2404® and LDX 2101® are now up and running. Lean duplex stainless steel is proving to be an ...
Germany - For any decision maker, hearing the information that is being presented to you is of paramount importance, and thanks to Tannoy's QFlex, district delegates in the town hall of Mid-Berlin are now hearing that information clearer ...
Tags: QFlex, meetings, Berlin town hall
A meta-analysis of Mederi Therapeutics' Stretta therapy demonstrated that the minimally invasive treatment using Stretta improves reflux symptoms and reduces esophageal acid exposure. Stretta Therapy, which involves delivery of ...
Tags: Stretta therapy, gastroesophageal reflux disease, medical management
The US Food and Drug Administration (FDA) has granted 510(k) approval to Medigus's SRS endoscopic system. The approval was based on a multi-center clinical trial which met a criteria of safety and efficacy in five countries and three ...
Tags: SRS endoscopic system, endoscopic system, SRS endoscope, the SRS system